⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HUMA News
Humacyte, Inc. Common Stock
Humacyte to Present at the H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
HUMA
Humacyte Announces FDA Authorization Extending Symvess Shelf Life to 36 Months
globenewswire.com
HUMA
Humacyte Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humacyte, Inc. - HUMA
businesswire.com
HUMA
Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions
globenewswire.com
HUMA
Humacyte Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humacyte, Inc. - HUMA
prnewswire.com
HUMA
Humacyte Announces Lancet Digital Health Publication of V007 Phase 3 Hemodialysis Access Trial Results
globenewswire.com
HUMA
Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”
globenewswire.com
HUMA
Form 8-K
sec.gov
HUMAW
HUMA
Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
HUMA
Humacyte Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humacyte, Inc. - HUMA
businesswire.com
HUMA